翰思艾泰生物医药科技（武汉）股份有限公司（“翰思艾泰-B”，股票代码：03378）于2026年5月26日公告，公司当日在香港联交所场内回购H股24,300股，约占该回购前已发行股本的0.018%。此次回购的最高价格为每股30.00港元，最低价格为27.98港元，成交量加权平均价格为28.7646港元，合计动用资金约69.90万港元（折合698,980港元）。
本次操作完成后，公司已发行股份（不包括库存股份）由此前的135,435,830股减少至135,411,530股，同时库存股份增至807,300股。公司此前于2026年2月12日获股东大会通过购回授权，授权购回总数为13,621,883股，截至本次回购后已购回807,300股，占获授权当日已发行股本约0.5926%。
公司确认本次回购已遵守香港联交所证券上市规则及相关法律规定，并完成了相应的内部批准及信息披露程序。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.